Proficiency Testing Program for Hb E (HBB: c.79G>A) Screening in Thailand Using Lyophilized Hb E Control Materials

被引:0
|
作者
Pornprasert, Sakorn [1 ]
Surajinda, Sirithorn [2 ]
Pongpunyayuen, Panida [2 ]
Punyamung, Manoo [2 ]
Ruengdit, Chedtapak [1 ]
Intasai, Nutjeera [1 ]
机构
[1] Chiang Mai Univ, Fac Associated Med Sci, Dept Med Technol, 110 Intawaroros Rd, Chiang Mai 50200, Thailand
[2] Chiang Mai Univ, Fac Associated Med Sci, Associated Med Sci Clin Serv Ctr, Chiang Mai, Thailand
关键词
Control materials; dichlorophenol-indophenol; Hb E (HBB c.79G > A); microcolumn chromatography; proficiency testing (PT) program; HEMOGLOBIN-E; THALASSEMIA;
D O I
10.1080/03630269.2020.1734612
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The dichlorophenol-indophenol (DCIP) test and microcolumn chromatography are simple methods commonly used for screening of Hb E (HBB: c.79G>A) in Thailand. However, there is no proficiency testing (PT) program for these screening tests. Thus, the aim of this study was to evaluate an efficiency of lyophilized hemoglobin (Hb) control materials used in the established PT program for Hb E screening at the Associated Medical Sciences-Clinical Service Center (AMS-CSC), Chiang Mai University, Chiang Mai, Thailand. Three cycles of PT were performed from June 2018 to July 2019. In each cycle, five different types of control materials were provided to the participants. Each participant analyzed the control materials in the same manner as in their routine practices for Hb E screening. The results showed that the number of participants increased from 95 in the first cycle to 126 and 134 in the second and third cycles, respectively. The numbers of participants who used the DCIP screening test and reported the result correctly increased from 79 (85.87%) to 106 (89.08%) and 112 (89.60%), respectively. Whereas those who used the microcolumn chromatography method and reported correct results were decreased from 100.0 to 85.71 and 66.67%, respectively. Thus, lyophilized Hb, control materials can be used effectively for the PT program of Hb E screening test. However, the further improvement, especially in skills of Hb E analysis by microcolumn chromatography, is required for some participating laboratories.
引用
收藏
页码:82 / 85
页数:4
相关论文
共 38 条
  • [31] Thalassemia major phenotype caused by HB Zurich-Albisrieden [α2 59(E8) Gly>Arg (HBA2:C.178G>C)] in a Brazilian child
    Pedroso, Gisele A.
    Kimura, Elza M.
    Santos, Magnun N. N.
    Albuquerque, Dulcineia M.
    Malimpensa, Danae
    Jorge, Susan E.
    Verissimo, Monica P. A.
    Costa, Fernando F.
    Sonati, Maria F.
    PEDIATRIC BLOOD & CANCER, 2018, 65 (12)
  • [32] Identification of a rare compound heterozygous hemoglobin variant β0-thal [β17(A14) Lys>Stop, HBB: c.52A>T] and Hb J-Lome [β59(E3) Lys>Asn, HBB: c.180G>C]
    Chen, Zixin
    Shao, Limei
    Jiang, Mingfeng
    Ma, Run
    Ping, Hongfen
    Wang, Zuo
    Ba, Xuejiao
    Ma, Bingjie
    Zhou, Tao
    HEMATOLOGY, 2022, 27 (01) : 946 - 950
  • [33] Two New γ Chain Variants: Hb F-Augusta GA [Gγ59 (E3)Lys → Arg; HBG2: c.179A>G] and Hb F-Port Royal-II [Aγ125(H3)Glu → Ala; HBG1: c.377A>C]
    Kutlar, Ferdane
    Ameri, Afshin
    Patel, Niren H.
    Zhuang, Lina
    Johnson, Lee E.
    Cheng, Michael L.
    Kutlar, Abdullah
    HEMOGLOBIN, 2014, 38 (05) : 376 - 380
  • [34] Successful Strategy of Pre-implantation Genetic Testing for Beta-Thalassemia (c.17A>T Mutation)-Hb E Disease Using Multiplex Fluorescent PCR and Mini-Sequencing
    Lattiwongsakorn, Worashorn
    Jansaka, Natpat
    Piyamongkol, Sirivipa
    Pantasri, Tawiwan
    Tongsong, Theera
    Suriya, Wanwisa
    Piyamongkol, Wirawit
    INTERNATIONAL JOURNAL OF WOMENS HEALTH AND REPRODUCTION SCIENCES, 2023, 11 (02): : 58 - 64
  • [35] De novo heterozygous Hb G-Waimanalo (α64(E13)Asp>Asn, CTG>CCG; HBA1:c.193G>A) variant in a sickle cell disease patient of an Indian tribe
    Kumar, Ravindra
    Mishra, Sweta
    Uikey, Ram Swaroop
    Gwal, Anil
    Mun, Amol
    Bharti, Praveen K.
    Shanmugam, Rajasubramaniam
    JOURNAL OF CLINICAL PATHOLOGY, 2021, 74 (05) : 336 - 338
  • [36] First Report of a Coincidental Discovery of Hb Shimonoseki [54(E3)GlnArg, HBA2: c.164A>G (or HBA1)] in a Greek Family
    Theodoridou, Stamatia
    Delaki, Evangelia
    Skatharoudi, Evangelia
    Karakasidou, Olga
    Vyzantiadis, Timoleon-Achilleas
    Theodoridis, Theodoros
    Chalkia, Panagiota
    HEMOGLOBIN, 2018, 42 (04) : 281 - 282
  • [37] Hemoglobin profile and molecular characteristics of the complex interaction of hemoglobin Doi-Saket [α9(A7) asn > lys, HBA2:c.30C > a], a novel α2α1 hybrid globin variant, with hemoglobin E [β26(B8) Glu > lys, HBB:c.79G > A] and deletional α+-thalassemia in a Thai family
    Panyasai, Sitthichai
    Khongthai, Kunyakan
    Satthakarn, Surada
    ANNALS OF MEDICINE, 2023, 55 (02)
  • [38] INTER-LAB EXCHANGE FOR HLA-E, -F AND -G TYPING USING NEXT GENERATION SEQUENCING APPROACHES IN AN EXTENSION EXPERIMENT IN THE CONTEXT OF THE DZA2021 EXTERNAL PROFICIENCY TESTING (EPT) PROGRAM FOR HLA TYPING
    Witter, Klaus
    Kutsch, Mareen
    Peter, Wolfgang
    Bangol, Barbara
    Schaefer, Marco
    Fuerst, Daniel
    Fae, Ingrid
    Hirv, Kaimo
    Dick, Andrea
    HLA, 2021, 98 : 9 - 10